...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >EVALUATION OF PLANT EXTRACTS AGAINST LUNG CANCER USING H460 CELL LINE
【24h】

EVALUATION OF PLANT EXTRACTS AGAINST LUNG CANCER USING H460 CELL LINE

机译:用H460细胞系评估肺癌提取物。

获取原文

摘要

Mammalian tumor cells show imperviousness to chemotherapy and its serious symptoms lessens the clinical adequacy of an extensive assortment of anticancer drugs. Plant-derived compounds show numerous valuable impacts and can restrain a few phases of malignancy of cancer. Despite there is paramount progress in cancer therapeutics in the last decades, the need to find, grow new and synergistic plant predicated anticancer specialists are in the developing stage. In the present study, we endeavored to exploit bioactive compounds of two plants viz. Limonia acidissima and Syzygium cumini , investigated their antiproliferative properties for lung cancer and evaluated the haemolytic activity. Methanol extracts of these plants were experimented for cytotoxic activity and found that L.acidissima and S.cumini selectively inhibited H 460 cell proliferation and found that the two plants are non-haemolytic. Our study deduce that the potential bioactive compounds of these plants have vibrant chance to fight lung cancer as were seen to be non-haemolytic to blood cells and they are very much recorded as a traditional medicine for various therapeutic uses.
机译:哺乳动物的肿瘤细胞显示不透化学疗法,其严重的症状降低了广泛种类的抗癌药物的临床适用性。植物来源的化合物显示出许多有价值的影响,并且可以抑制癌症恶性肿瘤的几个阶段。尽管在过去的几十年中癌症治疗取得了重大进展,但寻找,发展新的,具有协同作用的植物抗癌专家的需求仍处于发展阶段。在本研究中,我们致力于开发两种植物的生物活性化合物。柠檬酸柠檬和小茴香(Syzygium cumini),研究了它们对肺癌的抗增殖特性并评估了溶血活性。对这些植物的甲醇提取物进行了细胞毒性活性实验,发现酸乳酸杆菌和枯草杆菌选择性抑制H 460细胞增殖,发现这两种植物是非溶血性的。我们的研究推论出,这些植物的潜在生物活性化合物具有抗肺癌的强大活力,因为它被认为对血细胞不具有溶血作用,并且已被广泛记录为多种治疗用途的传统药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号